HERON THERAPEUTICS, INC. Business Finance Contracts & Agreements
30 Contracts & Agreements
- Exchange Agreements (1 contract)
- Facility Agreements (1)
- Note Agreements (3)
- Purchase Agreements (6)
- Registration Rights Agreements (2)
- Security Agreements (2)
- Stock Agreements (2)
- Underwriting Agreements (9)
- Waiver Agreements (2)
- Warrant Agreements (2)
- Working Capital Facility Agreement, dated August 9, 2023, by and among the Company, the several banks and other financial institutions or entities from time to time party thereto,... (Filed With SEC on August 14, 2023)
- Securities Purchase Agreement, dated July 21, 2023, by and among the Company and the Purchasers signatory thereto (Filed With SEC on July 24, 2023)
- Securities Purchase Agreement, dated August 8, 2022, by and among the Company and the Purchasers signatory thereto (Filed With SEC on August 10, 2022)
- Note Purchase Agreement, dated as of May 24, 2021, by and among Heron Therapeutics, Inc. and funds affiliated with Baker Bros. Advisors LP (Filed With SEC on May 25, 2021)
- Underwriting Agreement, dated October 3, 2019, among Heron Therapeutics, Inc. and Jefferies LLC, Cowen and Company, LLC and Evercore Group L.L.C., as representatives of the... (Filed With SEC on October 8, 2019)
- Underwriting Agreement, dated June 25, 2018, between Heron Therapeutics, Inc. and Jefferies LLC (Filed With SEC on June 28, 2018)
- Waiver, dated March 28, 2018, between Heron Therapeutics, Inc. and Tang Capital Partners, LP (Filed With SEC on April 3, 2018)
- Underwriting Agreement, dated December 4, 2017, between Heron Therapeutics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 7, 2017)
- WAIVER (Filed With SEC on January 24, 2017)
- 12,300,000 Shares of Common Stock HERON THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on January 24, 2017)
- SECURITY AGREEMENT (Filed With SEC on November 8, 2016)
- Pursuant to 17 CFR 20.24b-2, confidential information has been omitted in places marked *** and has been filed separately with theSecurities and Exchange Commission pursuant to a... (Filed With SEC on February 19, 2016)
- 4,800,000 Shares of Common Stock HERON THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on June 10, 2015)
- HERON THERAPEUTICS, INC. FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on June 27, 2014)
- 4,500,000 Shares of Common Stock and Pre-FundedWarrants to Purchase 600,000 Shares of Common Stock HERON THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on June 27, 2014)
- 150,000,000 A.P.PHARMA, INC. UNDERWRITING AGREEMENT (Filed With SEC on November 22, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 25, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 25, 2012)
- AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTES DUE 2021 (Filed With SEC on June 30, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 30, 2011)
- SECURITY AGREEMENT (Filed With SEC on April 28, 2011)
- SENIOR SECURED CONVERTIBLE NOTE DUE 2021 (Filed With SEC on April 28, 2011)
- SECURITIES PURCHASE AGREEMENT AMONG A.P. PHARMA, INC., TANG CAPITAL PARTNERS, LP, BAKER BROS. INVESTMENTS II, L.P., BAKER BROTHERS LIFE SCIENCES, L.P., AND 14159, L.P. DATED AS OF... (Filed With SEC on April 28, 2011)
- WARRANT TO PURCHASE SHARES OF COMMON STOCK OF A.P. PHARMA, INC. (Filed With SEC on October 22, 2009)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 22, 2009)
- A.P. PHARMA, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 22, 2009)
- A.P. PHARMA, INC. 1997 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on March 31, 2008)
- AMENDMENTS TO ADVANCED POLYMER SYSTEMS, INC. NON-QUALIFIED STOCK PLAN (Filed With SEC on November 14, 2007)
- A.P. PHARMA, INC. [ ] Sharesof Common Stock (Par Value $0.01 Per Share) UNDERWRITING AGREEMENT (Filed With SEC on May 25, 2007)
- Underwriting Agreement, dated March 28, 2018, among Heron Therapeutics, Inc. and Jefferies LLC, Cowen and Company, LLC and Evercore Group L.L.C., as representatives of the several... (Filed With SEC on April 3, 2018)
